Scarica l'app Stockscreener
78.79
4.89%
3.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$75.12
Aprire:
$75.73
Volume 24 ore:
938.80K
Relative Volume:
0.99
Capitalizzazione di mercato:
$3.69B
Reddito:
$1.35B
Utile/perdita netta:
$163.34M
Rapporto P/E:
24.05
EPS:
3.2763
Flusso di cassa netto:
$189.17M
1 W Prestazione:
+7.21%
1M Prestazione:
+53.92%
6M Prestazione:
+17.74%
1 anno Prestazione:
-7.77%
Intervallo 1D:
$75.62
$79.41
Intervallo di 1 settimana:
$73.04
$79.41
Portata 52W:
$47.31
$89.69
Haemonetics Corp Stock (HAE) Company Profile
Nome
Haemonetics Corp
Settore
Industria
Telefono
(781) 848-7100
Indirizzo
125 SUMMER STREET, BOSTON, MA
Confronta HAE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
78.79 | 3.52B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Reiterato | Barrington Research | Outperform |
| 2025-08-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-06-26 | Iniziato | Robert W. Baird | Outperform |
| 2025-02-07 | Downgrade | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Iniziato | JP Morgan | Overweight |
| 2024-11-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Iniziato | CL King | Buy |
| 2024-09-11 | Iniziato | BofA Securities | Neutral |
| 2024-09-10 | Iniziato | BTIG Research | Buy |
| 2024-06-12 | Aggiornamento | Needham | Hold → Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-01-27 | Downgrade | Needham | Buy → Hold |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Ripresa | Raymond James | Outperform |
| 2021-06-17 | Iniziato | Citigroup | Buy |
| 2021-05-14 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Iniziato | Needham | Buy |
| 2019-08-07 | Reiterato | Barrington Research | Outperform |
| 2019-05-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Reiterato | Barrington Research | Outperform |
| 2018-08-09 | Reiterato | Barrington Research | Outperform |
| 2018-02-07 | Reiterato | Barrington Research | Outperform |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Reiterato | Barrington Research | Outperform |
| 2017-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Reiterato | The Benchmark Company | Hold |
| 2016-09-20 | Downgrade | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Downgrade | Sidoti | Buy → Neutral |
| 2016-08-02 | Reiterato | Jefferies | Buy |
| 2016-08-02 | Reiterato | The Benchmark Company | Hold |
Mostra tutto
Haemonetics Corp Borsa (HAE) Ultime notizie
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Barchart.com
Haemonetics stock holds Buy rating at BTIG on plasma segment strength - Investing.com
HAE: BTIG Reiterates Buy Rating with $88 Price Target | HAE Stoc - GuruFocus
How currency fluctuations impact Haemonetics Corporation stockEarnings Risk Report & Daily Oversold Stock Bounce Ideas - newser.com
How Haemonetics Corporation (HAZ) stock reacts to fiscal policiesOptions Play & Long-Term Investment Growth Plans - newser.com
Can Haemonetics Corporation stock deliver consistent earnings growthAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Why retail traders accumulate Haemonetics Corporation stockWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Is Haemonetics Corporation stock at risk of policy regulation2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - newser.com
How Haemonetics Corporation stock correlates with oil marketsWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
How Haemonetics Corporation stock benefits from digital adoptionMarket Risk Report & Smart Allocation Stock Tips - newser.com
Why Haemonetics Corporation stock could outperform next yearEarnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
Key metrics from Haemonetics Corporation’s quarterly dataWeekly Risk Report & Reliable Volume Spike Alerts - newser.com
Is Haemonetics Corporation stock a buy on weakness2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
How Haemonetics Corporation stock reacts to oil prices2025 Technical Patterns & Risk Managed Investment Signals - newser.com
How Haemonetics Corporation stock reacts to stronger dollar2025 Risk Factors & Growth Focused Investment Plans - newser.com
Can Haemonetics Corporation (HAZ) stock stage a strong rebound this quarter2025 Dividend Review & Weekly Top Performers Watchlists - newser.com
Haemonetics (HAE) Price Target Increased by 11.07% to 88.03 - MSN
Interpreting Haemonetics (HAE) International Revenue Trends - Yahoo Finance
Is Haemonetics Corporation (HAZ) stock among top earnings playsJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
Using data filters to optimize entry into Haemonetics CorporationMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
A Look at Haemonetics’s (HAE) Valuation Following a 51% 30-Day Share Price Surge - Yahoo Finance
Using flow based indicators on Haemonetics CorporationWeekly Profit Analysis & Community Supported Trade Ideas - newser.com
Is Haemonetics’ (HAE) Shift to Profitability and Buybacks a New Capital Allocation Play? - simplywall.st
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
Can Haemonetics Corporation (HAZ) stock test all time highsLong Setup & Real-Time Chart Breakout Alerts - newser.com
Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $75 - 富途牛牛
How Haemonetics Corporation stock compares to industry benchmarksMarket Trend Summary & AI Powered Market Entry Ideas - Fundação Cultural do Pará
Why Haemonetics Corporation (HAZ) stock could rally stronglyQuarterly Investment Review & Safe Investment Capital Preservation Plans - Fundação Cultural do Pará
Blood Processing Equipments Market Projections 2025-2032: Key - openPR.com
Haemonetics Corp : Raymond James Raises Targe - 富途牛牛
Raymond James raises Haemonetics stock price target to $90 on strong results - Investing.com
A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $75 to $90 - 富途牛牛
Haemonetics Corp Azioni (HAE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):